Learning Hub

< BACK iPROLEPSIS Showcased at MEDICA 2025 Nov 25, 2025 Project presented by PLUX at an international medical technology trade fair MEDICA 2025 was held in Düsseldorf, Germany, from 17–20 November 2025 and is one of the largest international trade fairs for medical technology and healthcare. iPROLEPSIS was showcased by project partner PLUX at MEDICA 2025, within a shared exhibition space alongside other Portuguese entities. The event offered an opportunity to present the project to industry and healthcare stakeholders and to engage with a broad international audience. MEDICA 2025 2.HEIC MEDICA 2025 1.HEIC MEDICA 2025 2.HEIC 1/2 PREVIOUS NEXT

< BACK Highlights from IEEE EMBS 2024 Sep 5, 2024 Showcasing AI-Based Solutions for Psoriatic Arthritis Care Our project partner, PLUX Biosignals, participated in the 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS) , held in Orlando, Florida, USA, from July 15-19, 2024. During this prestigious event, PLUX presented the innovative work of the iPROLEPSIS project, which focuses on developing a novel, personalised digital care ecosystem for individuals with psoriatic arthritis. The world's largest international biomedical engineering conference, IEEE EMBS 2024 featured an extensive range of scientific tracks covering cutting-edge research and innovations in biomedical engineering and healthcare technology. Topics included women and children's health, translational clinical research, technology transfer, entrepreneurship, and biomedical engineering education. This event provided a valuable platform for showcasing the potential of AI-based solutions in improving care for psoriatic arthritis patients and highlighted the role of digital tools in revolutionizing personalised healthcare. 1/2 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search What are the symptoms of psoriatic arthritis? See related Handbook section PREVIOUS NEXT

< BACK iPROLEPSIS Games Presented at HiTech Program in Lisbon Jun 27, 2025 FMH/IST-ULisboa team showcased the project’s serious games to investors and health innovation experts On June 26, 2025, the iPROLEPSIS Games were presented during the final pitch session of the HiTech Program , held at the Thalia Theater in Lisbon, Portugal. Representing FMH/IST-ULisboa , Samuel Gomes , Bárbara Ramalho , and Filipa Magalhães introduced the iPROLEPSIS Games to an audience of investors and stakeholders interested in supporting innovative health solutions. This opportunity marked an important step in sharing iPROLEPSIS tools with a wider innovation and investment community. Read more about HiTech program here: https://hiseedtech.com/programs#header HiTech.jpg HiTech.jpg 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS: updates on user research and co-creation Oct 17, 2023 Co-creation sessions for advancing the development of the mIPROLEPSIS app iPROLEPSIS active engagement with users through ongoing co-creation sessions helps to advance the development of the mIPROLEPSIS app, scheduled for delivery before January 2024. In October 2023, the project partner Erasmus MC (EMC) conducted a co-creation session with patient partners to assess the User Interface (UI) of the PDPID-app. The focus was on improving usability, ensuring users’ understanding of expectations and enhancing users’ engagement to minimise missing data. The project partner FACULDADE DE MOTRICIDADE HUMANA (FMH-ULISBOA), is also developing storyboards for the personalised gaming suite . Three co-creation sessions were conducted: one with healthcare professionals and two with patient partners. Project partners The Centre for Research and Technology Hellas (CERTH) and FACULDADE DE MOTRICIDADE HUMANA (FMH-ULISBOA), in collaboration with the clinical partners, worked on identifying movements for the video analysis that will be included in the iPROLEPSIS-PDPID study. Multiple hand gestures and fullbody movements were identified for further assessment. Main points: mIPROLEPSIS App’s general looks and UI were approved by the patient partners; Despite being a data-collection app for research purposes, patients emphasise the significance of reviewing their own data entries; Participants noted a need for enhanced visual cues regarding specific activities in the app. Main points: Personalised gaming suite Smart games meant for disease management need to be highly tailored to the capabilities of the patients; Patients view gaming as a form of relaxation, emphasising the importance of stress-free design; Patient partners expressed interest in the proposed gaming categories. 1/0 PREVIOUS NEXT

< BACK Psoriasis Awareness Month - August 2024 Aug 20, 2024 From Psoriasis to Psoriatic Arthritis: The Importance of Awareness In August, we marked Psoriasis Awareness Month, raising awareness for the millions living with psoriasis, a chronic autoimmune disease that affects the skin and causes painful and itchy flare-ups. Beyond the visible symptoms, psoriasis can significantly impact mental health and overall quality of life. An important aspect of awareness is the link between psoriasis and psoriatic arthritis, a condition that develops in 20-40% of individuals with psoriasis. Psoriatic arthritis can lead to joint pain, stiffness, and swelling, potentially causing long-term disability if left untreated. This makes early detection and comprehensive management essential for improving patient outcomes. Through continued advocacy and education, we can help those affected by psoriasis seek timely support and prevent the progression to psoriatic arthritis. 1/4 PREVIOUS NEXT

< BACK 6th iPROLEPSIS Plenary Meeting Held in Oxford May 15, 2025 Partners Shared Progress and Plans for the Future The iPROLEPSIS consortium came together on 13–14 May 2025 for its 6th Plenary Meeting , hosted by the University of Oxford in the beautiful city of Oxford, UK. The two-day meeting covered updates on various parts of the project, including system development, clinical studies, data harmonisation, and user needs. It was a great opportunity for partners to share progress, discuss challenges, and align on next steps. Workshops helped address open issues and refine priorities for the coming months. On the first day, the consortium also welcomed feedback from the External Advisory Board , offering helpful guidance on recent developments. A warm thank you to the University of Oxford for hosting and to all participants for the active and constructive discussions! IMG_9529.jpg IMG_9431.jpg IMG_9527.jpg IMG_9529.jpg 1/8 PREVIOUS NEXT

< BACK iPROLEPSIS 5th Plenary Meeting in Athens Dec 5, 2024 Advancing the Development of Digital Solutions for Psoriatic Arthritis Care The iPROLEPSIS consortium gathered in Athens, Greece, on 2-3 December 2024, for the 5th Plenary Meeting. Hosted by Netcompany-Intrasoft and Wellics, this two-day event brought together consortium partners, the External Advisory Board (EAB), and the Project Officer (PO) to discuss key updates and map out the next steps in developing a personalised digital care ecosystem for people with Psoriatic Arthritis (PsA). The meeting focused on project updates, key achievements, and future plans for the Psoriatic Arthritis digital care ecosystem. Day 1 covered progress in the project, co-creation activities, and updates from various work packages. The team also demonstrated the iPROLEPSIS tools, including the miPROLEPSIS apps, HCP’s dashboard, and the Lifestyle Recommendation System. On Day 2, workshops were held on study designs, ecosystem development, and predictive models. Discussions also focused on data governance and dissemination strategies. 1/8 PREVIOUS NEXT

< BACK iPROLEPSIS Kick-Off Meeting Jan 8, 2023 iPROLEPSIS, a four-year Horizon Europe project on AI-enabled Psoriatic Arthritis screening, monitoring, and care, kicked off. iPROLEPSIS, a four-year H orizon Europe project on AI-enabled Psoriatic Arthritis screening, monitoring, and care, kicked off. Our consortium partners met in Thessaloniki, Greece, and during a two-day event laid the groundwork for this exciting research and innovation venture. The focus was placed on the four clinical studies that will be conducted in the project. News & Events iPROLEPSIS.png News & Events iPROLEPSIS.png 1/1 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search How will psoriatic arthritis affect me? Sleep and Fatigue See related Handbook section PREVIOUS NEXT

< BACK iPROLEPSIS Presented at Health Data Summit 2025 Mar 27, 2025 Showcasing practical strategies for high-quality data mapping and harmonisation At Health Data Summit 2025 , organised by the European Institute for Innovation Through Health Data (i~HD) on March 18–19 in Brussels , the iPROLEPSIS project was presented by Thanos Vidakis from AINIGMA Technologies . The presentation was part of the session titled: "Advanced Strategies and Tools for Ensuring High-Quality Data During Data Mapping". It focused on how iPROLEPSIS uses the OMOP Common Data Model (CDM) and OHDSI tools to harmonize health datasets from various sources. By applying coding standards such as SNOMED , the project ensures consistency and interoperability across data systems. The talk also highlighted recent hands-on workshops with data experts , during which real-world data was mapped to the OMOP model and underwent quality checks . These steps are essential in delivering analytics-ready health data — a key goal of the project. iPROLEPSIS continues to support high standards in digital health research by promoting data quality, standardisation, and collaboration across partners. 1/2 PREVIOUS NEXT

< BACK iPROLEPSIS Research on Digital Rheumatology Published in The Lancet eClinicalMedicine May 19, 2025 New Publication Highlights Explainable AI Tools, Digital Biomarkers, and Multimodal Disease Monitoring for PsA A recent paper published in The Lancet eClinicalMedicine presents the iPROLEPSIS initiative as a comprehensive European research effort aimed at transforming the diagnosis and management of psoriatic arthritis (PsA) through digital innovation and patient-centred care . The paper, titled "European advances in digital rheumatology: explainable insights and personalized digital health tools for psoriatic arthritis", outlines how iPROLEPSIS addresses critical gaps in current PsA care by combining real-world data , wearable sensors , and explainable artificial intelligence (xAI) models. Abstract The shift from traditional to technology-based diagnosis and management of psoriatic arthritis (PsA) represents a significant evolution in patient care. Traditionally, PsA was diagnosed and managed through clinical evaluations, physical examinations, and basic imaging techniques. With the evolution of digital technologies, PsA care is transforming, giving rise to the field of digital rheumatology. In this vein, Europe has invested in research initiatives, like iPROLEPSIS, that could accelerate this transformation and redefine PsA care within a digital world. In this Viewpoint we present the current clinical PsA landscape, highlight the PsA patients’ interaction with the digital world, and showcase the novel iPROLEPSIS digital offerings. The latter scaffold digital rheumatology by identifying PsA key drivers. Moreover, they support personalized PsA risk prediction and improve early PsA detection. Furthermore, they enable precise PsA treatment strategies and digital therapeutics within a novel digital health ecosystem. Read the full paper here: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00175-0/fulltext PIIS2589537025001750 .pdf Download PDF • 1.20MB Lancet publication.png Lancet publication.png 1/1 PREVIOUS NEXT